What is Celgene Patient Support®?

Helping your patients access ABRAXANE

Celgene Patient Support

Celgene Patient Support® provides your office with a dedicated, central point of contact that helps you and your patients access Celgene Oncology products, including ABRAXANE. Regardless of the patient’s insurance situation, Celgene Patient Support® has a variety of services and assistance options available.

Celgene Patient Support® assists with obtaining insurance approval and helps to identify financial assistance options for ABRAXANE

Financial Assistance Options*
  • Celgene Commercial Co-pay Program
  • Co-payment/Co-insurance assistance through third-party organizations
  • Celgene Free Medication Program
  • Transportation assistance
Insurance-Related Services
  • Benefits investigation
  • Help with prior authorization/precertification
  • Appeals assistance after insurance denial
  • Researching alternative coverage options
*Subject to eligibility requirements.

Assistance is just a phone call away

To get started, call us at 1-800-931-8691 Monday-Friday 8 AM ‐ 7 PM EST or send us an e-mail.

Enroll online now

access-here patient-support-btn

What is Celgene Patient Support®?

Helping your patients access ABRAXANE

Celgene Patient Support® provides your office with a dedicated, central point of contact that helps you and your patients access Celgene Oncology products, including ABRAXANE. Regardless of the patient’s insurance situation, Celgene Patient Support® has a variety of services and assistance options available.

Celgene Patient Support® assists with obtaining insurance approval and helps to identify financial assistance options for ABRAXANE

Financial Assistance Options*
  • Celgene Commercial Co-pay Program
  • Co-payment/Co-insurance assistance through third-party organizations
  • Celgene Free Medication Program
  • Transportation assistance

Insurance-Related Services

  • Benefits investigation
  • Help with prior authorization/precertification
  • Appeals assistance after insurance denial
  • Researching alternative coverage options
*Subject to eligibility requirements.

Assistance is just a phone call away

To get started, call us at 1-800-931-8691 Monday-Friday 8 AM ‐ 7 PM EST or send us an e-mail.

Enroll online now

access-here patient-support-btn
patient-support-btn
aSubject to eligibility requirements.

INDICATIONS

ABRAXANE is indicated for:

  • The treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated
  • The first-line treatment of locally advanced or metastatic non–small cell lung cancer, in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy
  • The first-line treatment of patients with metastatic adenocarcinoma of the pancreas, in combination with gemcitabine

INDICATIONS

ABRAXANE is indicated for:

  • The treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated
  • The first-line treatment of locally advanced or metastatic non–small cell lung cancer, in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy
  • The first-line treatment of patients with metastatic adenocarcinoma of the pancreas, in combination with gemcitabine